Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Diabetes Obesity and Metabolism
JournalCitation impact & published research
Diabetes Obesity and Metabolism is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 7,929 works, 240,631 citations, an h-index of 186 and an APC (USD) of 4,940.
7,929
Works
240,631
Citations
186
h-index
4,940
APC (USD)
IDs:OpenAlex
What are the most-cited papers on Diabetes Obesity and Metabolism?
ScholarIQmost cited works
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension
John Wilding, Rachel L. Batterham, Melanie J. Davies, Luc F. Van Gaal, Kristian Kandler, Katerina Konakli, Ildiko Lingvay, Barbara McGowan, Tuğçe Kalaycı Oral, Julio Rosenstock, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Robert F. Kushner, STEP 1 Study Group
Diabetes Obesity and Metabolism. 2022988 CitationsOPEN ACCESS
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Robert Ćhilton, I. Tikkanen, Christopher P. Cannon, S. Crowe, Hans J. Woerle, Uli C. Broedl, Odd Erik Johansen
Diabetes Obesity and Metabolism. 2015517 CitationsOPEN ACCESS
Efficacy and safety of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes mellitus: systematic review and network meta‐analysis
Francesco Zaccardi, David R. Webb, Zin Zin Htike, Dina Ahmed Hosney Youssef, Kamlesh Khunti, Melanie J. Davies
Diabetes Obesity and Metabolism. 2016490 Citations
Why do <scp>SGLT2</scp> inhibitors reduce heart failure hospitalization? <scp>A</scp> differential volume regulation hypothesis
Karen Melissa Hallow, Gabriel Helmlinger, Peter J. Greasley, John J.V. McMurray, David W. Boulton
Diabetes Obesity and Metabolism. 2017487 CitationsOPEN ACCESS
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
Jan Bolinder, Östen Ljunggren, Lars Johansson, John Wilding, AM Langkilde, C. David Sjöström, Jennifer Sugg, Shamik Parikh
Diabetes Obesity and Metabolism. 2013484 CitationsOPEN ACCESS
Related on ScholarIQ
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension
Paper
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Paper
Efficacy and safety of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes mellitus: systematic review and network meta‐analysis
Paper
Why do <scp>SGLT2</scp> inhibitors reduce heart failure hospitalization? <scp>A</scp> differential volume regulation hypothesis
Paper
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
Paper
Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity
Paper